Medical/Pharmaceuticals News & Press Release Distribution

Medical/Pharmaceuticals

APAC
Global

I-Mab Expands Global Presence with New Hong Kong Office

SHANGHAI and ROCKVILLE, Md., May 20, 2020 /PRNewswire/ -- I-Mab (NASDAQ:IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical needs, particularly ...

2020-05-20 16:00 7835

It's time to talk: Relationships Australia NSW launches free telephone hotline

SYDNEY, May 20, 2020 /PRNewswire/ -- Relationships Australia NSW has launched Time 2 Talk, a brand-new telephone hotline that provides support and advice to help Australians navigate the complexities of day-to-day living amid COVID-19. Time 2...

2020-05-20 14:28 2899

It's time to talk: Relationships Australia NSW launches free telephone hotline

DKSH partners with International SOS to safeguard staff and supply chain operations during COVID-19

BANGKOK, May 20, 2020 /PRNewswire/ -- DKSH, Asia's leading Market Expansion Services provider for companies seeking to grow their business inAsia and beyond, has entered into a partnership with International SOS, to run DKSH's Total Quarantine Solution in several markets acrossAsia.

2020-05-20 12:00 2686

DKSH partners with International SOS to safeguard staff and supply chain operations during COVID-19

VSMS ECG Patch receives US FDA 'Emergency Use Authorisation' for patients being treated for COVID-19

* Patch now authorised in the USA for emergency use for patients undergoing treatment for COVID-19 * Patch entitled for reimbursement under US CPT code scheme – adds to GMV's growing revenue profile * Large addressable market for G Medical - ~1.5m confirmed cases of COVID-19 recorded in the...

2020-05-20 10:50 1222

Duke-NUS, GenScript and A*STAR launch first-in-the-world SARS-CoV-2 serology test to detect neutralising antibodies without need of containment facility or specimen

* As a first-in-the-world "rapid smart test kit", the cPass™ which can measure neutralising antibodies in an hour will be a huge boost to current COVID-19 investigations, from contact tracing, sero-prevalence survey, and assessment of herd immunity, longevity of protective immunity and efficacy...

2020-05-20 10:40 7377

Samsung Biologics Expands Business Continuity Excellence with Additional ISO22301 Certification

SONGDO, South Korea, May 19, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) announced it has attained ISO22301 certification for additional business operations, demonstrating its unsurpassed commitment to ensuring client satisfaction and operational excellence through its world-class business...

2020-05-20 07:11 1856

Samsung Biologics Expands Business Continuity Excellence with Additional ISO22301 Certification

VolitionRx Announces Proposed Underwritten Public Offering of Common Stock

AUSTIN, Texas, May 19, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company that applies its Nucleosomics™ platform through its subsidiaries to develop simple, easy to use, cost-effective blood tests to help diagnose a range of cancers a...

2020-05-20 04:01 8486

Glemser Technologies and Arria NLG announce strategic partnership

Together they will accelerate pharma clients' ability to bring life-saving drugs to market through automation of medical and regulatory report writing NEW YORK, May 20, 2020 /PRNewswire/ -- Arria NLG, a leading provider of Natural Language Generation (NLG) technology, today announced a collaborat...

2020-05-20 01:45 3373

Glemser Technologies and Arria NLG announce strategic partnership

Covis Pharma B.V. Initiates Phase 3 Clinical Trial of Alvesco (Ciclesonide) Inhaler for the Treatment of COVID-19

U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) filing to study the use of Alvesco in COVID-19 Study will evaluate the Safety and Efficacy of Alvesco in the Treatment of Non-hospitalized COVID-19 Patients Aged 12 and Above LUXEMBOURG and ZUG, Swi...

2020-05-19 20:00 1665

TauRx Reveals Study Results That Offers New Hope for Treatment of Patients With Dementia

Minimum dose of hydromethylthionine could slow clinical decline and brain atrophy in behavioural variant Fronto-Temporal Dementia as well as Alzheimer's Disease ABERDEEN, Scotland and SINGAPORE, May 19, 2020 /PRNewswire/ -- In a paper published online in theJournal of Alzheimer's Disease ( https...

2020-05-19 19:00 2305

QPS Continues to Expand UPLC-HRMS Quantitation Capabilities to Support Gene Therapy and Protein Drug Development

NEWARK, Delaware, May 19, 2020 /PRNewswire/ -- QPS, a global contract research organization (CRO) that provides discovery, preclinical, and clinical drug development services, is reinforcing its focus on qualitative and quantitative bioanalysis of biotherapeutics. QPS announces an expanded and up...

2020-05-19 18:55 3029

QPS Continues to Expand UPLC-HRMS Quantitation Capabilities to Support Gene Therapy and Protein Drug Development

Invivoscribe Announces FDA Approval for Distribution of the LeukoStrat CDx FLT3 Mutation Assay as an IVD Kit in the United States

SAN DIEGO, May 19, 2020 /PRNewswire/ -- Invivoscribe to offer the LeukoStrat® CDxFLT3 Mutation Assay as an FDA approved kit with analysis software. In 2017, Invivoscribe's LeukoStrat® CDx FLT3 Mutation Assay became the first FDA approvedFLT3 test and launched as a testing service at LabPMM, Invi...

2020-05-19 18:00 2914

Half-year Figures: ZEISS Looks Back on Good First Six Months Overall

Half-year revenue reaches 3.2 billion euros (+6% compared to prior year) – EBIT at455 million euros (+12 million euros compared to prior year) - The Semiconductor Manufacturing Technology and Medical Technology segments contributed in particular to growth in the first six months - Initial impact...

2020-05-19 17:00 2111

Mentice Launches Seventh Generation Platform Aimed to Transform Endovascular Therapy

VIST® G7 Brings Reality to Complex Interventions and Introduces a Scalable and Flexible Platform for Advanced Future Applications GOTHENBURG, Sweden, May 19, 2020 /PRNewswire/ -- Mentice AB (STO: MNTC), today announced the global introduction of its seventh-generation simulation platform - VIST®...

2020-05-19 16:20 2060

Chinese company Daddybaby applies for international PPE certification

FUZHOU, China, May 19, 2020 /PRNewswire/ -- Daddybaby Co. Ltd. has retooled its production lines and joined the fight to deliver more personal protective equipment (PPE) to the populations in many countries. As the daily number of COVID-19 infections inChina has significantly dropped and the situ...

2020-05-19 14:55 1541

Excelra to Provide Lawrence Livermore National Laboratory With Small Molecule Medicinal Chemistry Intelligence Data to Help Develop Drug Design Platform

HYDERABAD, India, May 19, 2020 /PRNewswire/ -- Under a three-year agreement, Excelra – a leading global data and analytics company – will provide Lawrence Livermore National Laboratory (LLNL) withGOSTAR , a small molecule medical chemis...

2020-05-19 10:00 2947

Aetna International announces partnership with leading mental well-being app Wysa, as part of enhanced mental well-being support for members during COVID-19 pandemic

SINGAPORE, May 19, 2020 /PRNewswire/ -- Aetna International has today announced that it is partnering with Wysa, a confidential and anonymous mental well-being app and service, as part of the company's ongoing efforts to address the 'second curve' of the COVID-19 pandemic, the less visible but in...

2020-05-19 10:00 3511

Zai Lab Announces First Chinese Patient Dosed in the Global Phase 3 ATTACK Trial of Sulbactam- Durlobactam for Patients with Carbapenem-Resistant Acinetobacter Infections

SHANGHAI and SAN FRANCISCO, May 19, 2020 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB), an innovative commercial stage biopharmaceutical company, today announced dosing of the first Chinese patient in the global ATTACK (Acinetobacter Treatment Trial Against Colistin) Phase 3 registrational trial...

2020-05-19 09:45 3125

Exyte and Univercells Technologies combine forces for rapid deployment of vaccine production plants in the wake of the COVID-19 pandemic

* Exyte offers the new ExyCell® modular technology for fast-track construction of biologicals production facilities compliant with the current good manufacturing practice (cGMP). * Univercells Technologies delivers the integrated NevoLine™ biomanufacturing platform, including scale-X™ bioreac...

2020-05-19 08:15 4642

Exyte and Univercells Technologies combine forces for rapid deployment of vaccine production plants in the wake of the COVID-19 pandemic

WuXi Biologics Closes Land Deal to Build State-of-the-Art Biologics Production Facility in the United States

SHANGHAI and WORCESTER, Mass., May 19, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, and the Worcester Business Development Corporation (WBDC) announced today the successful signing of a land deal for WuXi Bio...

2020-05-19 08:00 2849

1 ... 564 565 566567568 569 570 ... 608